MarketPulse

pediatric treatment

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Pharming Group N.V.

Pharming Wins Japan Approval for Joenja, First APDS Treatment for Young Children

Pharming secures Japan approval for Joenja, first APDS treatment for children aged 4-11 globally, based on positive Phase III data showing lymphadenopathy reduction and immune function improvement.
PHARpediatric treatmentorphan drug
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Eton Pharma Gains FDA Clearance for First Liquid Desmopressin Formulation

Eton Pharma gains FDA approval for DESMODA, the first liquid desmopressin formulation for central diabetes insipidus, launching March 9 with projected peak sales of $30-50 million.
ETONFDA approvalrare disease